World Health Organization Disability Assessment Schedule II (WHODAS-II) for Patients With Symptomatic Lumbar Spinal Stenosis
- Conditions
- Lumbar Spinal Stenosis
- Interventions
- Other: WHODAS II (World Health Organization Disability Assessment Schedule II)
- Registration Number
- NCT00480311
- Lead Sponsor
- Kovacs Foundation
- Brief Summary
The main purpose of this study is to determine the measurement characteristics of WHODAS-II (World Health Organization Disability Assessment Schedule II), as well as to analyze its correlation with symptomatic lumbar spinal stenosis (Visual Analog Scale, VAS), disability (Spanish version of the Roland Morris Questionnaire, RMQ), fear avoidance beliefs and attitudes (Spanish version of the FAB Questionnaire, FABQ), and quality of life (SF-12). Measurements will be taken at baseline and 6 days later (day 7).
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- All
- Target Recruitment
- 200
- Patients seen for symptomatic lumbar spinal stenosis
- With signs of neurogenous claudication
- MRI or CAT scan concordant with observed signs
- Able to read and write
- Have signed the informed consent form
- Central nervous system pathology (with or without treatment)
- Diagnosis of rheumatic inflammatory disease or fibromyalgia
- Red flags for underlying systemic disease
- Criteria for diagnosis of disc herniation
- Symptoms suggesting saddle anesthesia, cauda equina, loss of sphincter tone or paraparesis
- Motor deficit that progresses or does not improve in 6 weeks
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description 1 WHODAS II (World Health Organization Disability Assessment Schedule II) Measurement characteristics of WHODAS II (World Health Organization Disability Assessment Schedule).
- Primary Outcome Measures
Name Time Method Measurement characteristics of WHODAS-II At baseline and at 7 days
- Secondary Outcome Measures
Name Time Method Correlation between WHODAS-II and VAS, RMQ, FABQ and SF-12 in symptomatic lumbar spinal stenosis At baseline and at 7 days
Trial Locations
- Locations (1)
Hospital Universitario Marqués de Valdecilla
🇪🇸Santander, Cantabria, Spain